News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AlgoNomics To Raise 1.5 million Euro


6/20/2007 1:36:09 PM

GHENT, Belgium--(BUSINESS WIRE)--AlgoNomics NV, the immunoprofiling company, announced today that it raised 1.5 million euro (about 2.0 million USD) to further accelerate the development of its in vitro screening platform that expands the company’s existing immunogenicity screening services and tools. The patented Epibase® screening tool is currently widely applied for the immunogenicity screening and optimization of biotherapeutics, such as therapeutic antibodies, biosimilars and vaccines.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES